|
|
Conferences & Courses
|
Next Generation Dx Summit
August 19-21, 2014 | Washington, DC
The Sixth Annual Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Detection of Infectious Disease and Pathogens, Companion Diagnostics, Commercialization of Molecular Diagnostics, Inherite
|
|
Enabling Point-of-Care Diagnostics
August 19-20, 2014 | Washington, DC
The Sixth Annual Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Detection of Infectious Disease and Pathogens, Companion Diagnostics, Commercialization of Molecular Diagnostics, Inherite
|
|
Predictive Cancer Biomarkers
August 19-20, 2014 | Washington, DC
The Sixth Annual Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Detection of Infectious Disease and Pathogens, Companion Diagnostics, Commercialization of Molecular Diagnostics, Inherite
|
|
|
|
Life Science Media Library
|
Laboratory Developed Tests
May 7, 2013 |
Laboratory-developed tests, which are developed, validated and performed by clinical laboratories, have come under increased scrutiny by the FDA. Cambridge Healthtech Institute's Laboratory-Developed Tests DVD will cover the latest developments from the FDA and the positions and recommendations put forward by medical and industry professional societies; the challenges of meeting CLIA regulations in the new age of genomics; and the complexities of implementing NGS assays into clinical laboratories.
|
qPCR in Molecular Diagnostics
February 12, 2013 |
Quantitative real-time PCR is a valuable technology used for diagnostics of diseases such as cancer and infectious diseases, and for the detection of bacterial, fungal and viral pathogens. This course covers aspects of incorporating qPCR into standard molecular diagnosis including the challenges involved, an overview of the technology available, and next steps.
|
Strategies for Companion Diagnostic Development
September 19, 2012 |
In these presentations selected from the Strategies for Companion Diagnostic Development workshop at the Fourth Annual ADAPT Congress 2012, global IVD leaders and experienced consultants address the potential downstream effects of early decisions in the development cycle of companion diagnostics, what are the strategies to achieve successful commercialization of IVD products, how collaborative partnerships drive results and are models for successful development, and when and how a companion diagnostic should be included in drug trials.
|
|
|
|
Publications, Reports, & Whitepapers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|